Oncology & Cancer

Cancer DNA blood tests validated by international research team

An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing—a fast, cheap and less invasive method to diagnose and monitor cancer.

Oncology & Cancer

Bacterial molecule may be key to fighting stomach cancer

Humans are exposed to many types of bacteria daily, the majority of which are harmless. However, some bacteria are pathogenic, which means they can cause disease. An extremely common pathogenic bacterial infection is Helicobacter ...

Oncology & Cancer

Predicting mutated gene associated with melanoma

Although risk for melanoma, the most serious type of skin cancer, is often associated with ultraviolet light exposure, genetic factors are also at play, with some families being more prone to the disease than others.

Oncology & Cancer

Researchers identify genes behind uterine leiomyosarcoma

In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS). Furthermore, using fully sequenced patient-derived xenografts, the team has preclinically validated new ...

Oncology & Cancer

Case study of rare nervous system tumor reveals hypermutation

While deadly, gliosarcomas are a rare central nervous system tumor often overshadowed in research by more common tumors. These sarcomas can occur either in the brain or the spine (the latter is much less common).

Oncology & Cancer

Rapid genetic testing can help women choose breast cancer treatment

Women with breast cancer who are offered rapid genetic testing for BRCA1 and BRCA2 mutations—and who are able to receive their genetic test results prior to selecting treatment—were more likely to choose to have a bilateral ...

page 1 from 40